In the same study, CD3E was highlighted as a substantial regulator of the tumor microenvironment, since CD4+ memory T-cells and regulatory T-cells were found to be negatively correlated with CD3E expression levels [60], while in low-grade glioma patients, CD3E upregulation served as a marker of significantly worse prognosis [62]. This evidence concerns the gene CD4 and neoplasm.